Biosimulation Trends and Forecast
The future of the global biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research Institution markets. The global biosimulation market is expected to reach an estimated $6.8 billion by 2030 with a CAGR of 13.5% from 2024 to 2030. The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software, and growing R&D expenditures in the biotechnology and pharmaceutical sectors.Biosimulation by Segment
The study includes a forecast for the global biosimulation by delivery model, product, application, end use, and region.Biosimulation Market by Delivery Model [Shipment Analysis by Value from 2018 to 2030]
- Subscription Models
- Ownership Models
Biosimulation Market by Product [Shipment Analysis by Value from 2018 to 2030]
- Software
- Services
Biosimulation Market by Application [Shipment Analysis by Value from 2018 to 2030]
- Drug Development
- Drug Discovery
- Others
Biosimulation Market by End Use [Shipment Analysis by Value from 2018 to 2030]
- Pharmaceutical & Biotechnology Companies
- CROs
- Regulatory Authorities
- Academic Research Institutions
Biosimulation Market by Region [Shipment Analysis by Value from 2018 to 2030]
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Biosimulation Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities aCROss the value chain. With these strategies biosimulation companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biosimulation companies profiled in this report include-- Certara
- Dassault
- Advanced Chemistry Development
- Simulation
- Schrodinger
- Chemical Computing Group
- Physiomics
- Rosa & Co
- BioSimulation Consulting
- Genedata
Biosimulation Market Insights
The publisher forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.
Features of the Global Biosimulation Market
- Market Size Estimates: Biosimulation market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Biosimulation market size by various segments, such as by delivery model, product, application, end use, and region in terms of value ($B).
- Regional Analysis: Biosimulation market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different delivery model, product, application, end use, and regions for the biosimulation market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biosimulation market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the biosimulation market size?Answer: The global biosimulation market is expected to reach an estimated $6.8 billion by 2030.
Q2. What is the growth forecast for biosimulation market?
Answer: The global biosimulation market is expected to grow with a CAGR of 13.5% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the biosimulation market?
Answer: The major drivers for this market are expanding markets for biosimilars and biologics, increasing number of regulatory organizations using biosimulation software and increasing r&d expenditures in the biotechnology and pharmaceutical sectors.
Q4. What are the major segments for biosimulation market?
Answer: The future of the biosimulation market looks promising with opportunities in the pharmaceutical & biotechnology company, CROs, regulatory authority, and academic research institution markets.
Q5. Who are the key biosimulation market companies?
Answer: Some of the key biosimulation companies are as follows:
- Certara
- Dassault
- Advanced Chemistry Development
- Simulation
- Schrodinger
- Chemical Computing Group
- Physiomics
- Rosa & Co
- BioSimulation Consulting
- Genedata
Answer: The publisher forecasts that drug development will remain the larger segment over the forecast period due to the growing number of government efforts encouraging the use of sophisticated software.
Q7. In biosimulation market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the existence of key players, increased healthcare digitalization, and the rising prevalence of chronic health concerns.
Q.8 Do we receive customization in this report?
Answer: Yes,the publisher provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the biosimulation market by delivery model (subscription models and ownership models), product (software and services), application (drug development, drug discovery, and others), end use (pharmaceutical & biotechnology companies, CROs, regulatory authorities, and academic research institutions), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Biosimulation Market: Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Certara
- Dassault
- Advanced Chemistry Development
- Simulation
- Schrodinger
- Chemical Computing Group
- Physiomics
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
